hrp0098p3-272 | Late Breaking | ESPE2024

Pseudo-hyperkalaemia in Congenital Adrenal Hyperplasia – A Challenge for Clinicians

Gunasekara Buddhi , Wadey Hannah , Aitkenhead Helen , Gunasekara Antonia

Background: Hyperkalaemia, defined as potassium levels above 5.5 mmol/L, is a potentially life-threatening condition commonly seen in congenital adrenal hyperplasia (CAH). Pseudohyperkalaemia is a false elevation of potassium observed in vitro, caused by potassium moving out of cells (erythrocytes, leukocytes, or platelets) during or after blood sampling. This is often linked to high platelet counts (>450 × 10^9/L), due to potassium release from activ...

hrp0098p2-11 | Adrenals and HPA Axis | ESPE2024

Iatrogenic adrenal insufficiency – a single centre response to increasing awareness and instituting management in non-endocrine specialities.

Tollerfield Sally , Atterbury-Todd Abigail , Wadey Hannah , Edmondson Claire , Moodey Nicola , Morris Stacey , Enright Noelle , Soo Audrey , Gan Hoong-Wei , Amin Rakesh , Shaunak Meera , Dattani Mehul , Hoskins Steve , Katugampola Harshini

Introduction: Supra-physiological doses of steroids are frequently used in the management of non-endocrine conditions, including chronic respiratory disease and epilepsy. Long-term use risks iatrogenic adrenal insufficiency (AI), necessitating professional and family education on management of intercurrent illness and adrenal crisis.Aims: To design and implement a Trust-wide pathway for steroid prescribers on the managem...